The role will also lead financial modeling across Budget, Forecast, and Long-Range Planning (LRP) processes and support business development initiatives through valuation modeling and scenario analysis for licensing, partnership, and acquisition opportunitiesKey Responsibilities Candidates must demonstrate deep expertise in pharmaceutical revenue and market access finance. Ideal candidates will have:
Commercial Business Partnership
Revenue Forecasting & ASP Modeling (Subject Matter Expert)
Gross-to-Net (GTN) Leadership
Medicare Part B Buy-and-Bill Expertise
Budget, Forecast & Long-Range Planning
Commercial OPEX & Headcount Planning
Business Development Financial Modeling
Qualifications
Candidates without direct experience in pharmaceutical Gross-to-Net and ASP-based revenue modeling will not be considered.

Helsinn is a global pharmaceutical company that builds, manufactures, launches, and commercializes products to improve the quality of life for patients with cancer and chronic disease, with a focus on supportive care, oncology, and dermato-oncology.
Founded in 1976, Helsinn has nearly 50 years of experience in the pharmaceutical industry, with an extensive network of long-standing trusted partners enabling a commercial presence in about 90 countries.
Headquartered in Lugano, Switzerland, Helsinn Healthcare SA defines and implements the Group’s strategy, overseeing its three subsidiaries: Helsinn Birex Pharmaceuticals Ltd. (Ireland), Helsinn Therapeutics (U.S.), Inc., and Helsinn Pharmaceuticals (Beijing) Co., Ltd.
Our mission is to champion and support patients with cancer and chronic diseases at every stage of their journey, by providing them with the best medications and solutions based on their needs and preferences.
🔹Follow us to stay informed about the latest news from Helsinn Group.
🔹Interested in joining our team? Visit www.helsinn.com and explore the “Careers – Join us” section to apply via the appropriate country portal.
* This account shall only be used to share news concerning Helsinn. We would like to emphasize that due to the highly regulated nature of the pharma industry, we cannot engage with you online in any discussions concerning our or other companies’ products and/or services, and/or treatment options. It is best to hold such discussions and to seek guidance privately from your healthcare professional.